ZHBIO: Oral absorbable biological membrane completes the enrollment of the first subject

ZHBIO announced that the company's research and development project "Oral Resorbable Biomembrane" has officially entered clinical trials. This clinical trial is a multicenter, randomized controlled, single-blind, non-inferiority trial aimed at evaluating the efficacy and safety of the oral resorbable biomembrane for guiding bone regeneration. Currently, the project has successfully completed the random enrollment of the first subject. The oral resorbable biomembrane, as a decellularized dermal matrix material, can provide a good scaffold for cell ingrowth and migration, thereby guiding the growth and deposition of bone tissue to achieve reparative regeneration in bone defect areas